{
  "335ed9ab15e1d9ff": {
    "source": "pubmed",
    "title": "Saliva-based molecular diagnostics in oral squamous cell carcinoma (OSCC): a non-invasive frontier in oncology.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658283"
  },
  "f4e882985d3f7914": {
    "source": "pubmed",
    "title": "Salivary miR-34a Exhibits State-Dependent Dysregulation Across Normal Oral Mucosa, Premalignant Lesions and Oral Squamous Cell Carcinoma.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658295"
  },
  "8be2c329244d80bd": {
    "source": "pubmed",
    "title": "A Novel Protein Serum Biomarker Assay for Tracking (Neo)adjuvant and Metastatic Therapy Efficacy and Enabling the Timely Detection of Relapse in Breast Cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658299"
  },
  "a27dc266d4222f4f": {
    "source": "pubmed",
    "title": "Liquid Biopsy and Multi-Omic Biomarkers in Breast Cancer: Innovations in Early Detection, Therapy Guidance, and Disease Monitoring.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658302"
  },
  "fcde032cf0577286": {
    "source": "pubmed",
    "title": "Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658304"
  },
  "009f2b0165cf4467": {
    "source": "pubmed",
    "title": "Precision Medicine and Artificial Intelligence in Next-Generation Cancer Surgery: A Comprehensive Analysis of Clinical Applications, Therapeutic Outcomes, and Implementation Strategies.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658306"
  },
  "5ea090e8ffbb9ff1": {
    "source": "pubmed",
    "title": "Tumor-derived extracellular vesicles and genitourinary cancers: from biological mechanisms to clinical applications.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658310"
  },
  "0bcea1adaa995b83": {
    "source": "pubmed",
    "title": "Biosensors based on liquid biopsy for clinical cancer diagnosis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658312"
  },
  "7e76eae3fd95f984": {
    "source": "pubmed",
    "title": "Machine perception liquid biopsy identifies brain tumours via systemic immune and tumour microenvironment signature.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658314"
  },
  "2a9a922da7d87cb7": {
    "source": "pubmed",
    "title": "Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658316"
  },
  "d7745df9a496001a": {
    "source": "pubmed",
    "title": "Circular RNAs as biomarkers and targets in ovarian cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658319"
  },
  "b98731b422163268": {
    "source": "pubmed",
    "title": "Digging into the Solubility Factor in Cancer Diagnosis: A Case of Soluble CD44 Protein.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658321"
  },
  "b7c83791f84294ea": {
    "source": "pubmed",
    "title": "Identification of Actionable Mutations in Metastatic Castration-Resistant Prostate Cancer Through Circulating Tumor DNA: Are We There Yet?",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658323"
  },
  "78401283a8666f5e": {
    "source": "pubmed",
    "title": "A machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658325"
  },
  "57da0ac894c2912e": {
    "source": "pubmed",
    "title": "Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658327"
  },
  "4fb516632f743cbc": {
    "source": "pubmed",
    "title": "Extracellular vesicles-derived non-coding RNA in leukemias and pre-leukemic syndromes: a systematic review.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658329"
  },
  "dfa302f68de26713": {
    "source": "pubmed",
    "title": "Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658331"
  },
  "d02097e401a10933": {
    "source": "pubmed",
    "title": "Recent advances in the early detection of ovarian Cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658333"
  },
  "97af702b9e030a7a": {
    "source": "pubmed",
    "title": "miRquad: first-in-class dPCR multiplex TaqMan\u2122 Advanced clinical research assay for microRNA detection in head and neck cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658337"
  },
  "06fc5da274628ce6": {
    "source": "pubmed",
    "title": "Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence Population.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658339"
  },
  "814000549137e9ed": {
    "source": "pubmed",
    "title": "Tumor-Informed Liquid Biopsy for Monitoring Thyroid Cancer: A Proof-of-Concept Study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658341"
  },
  "98006fce833f8835": {
    "source": "pubmed",
    "title": "Subtype-specific prognostic implications of plasma-detected PIK3CA mutations in Vietnamese breast cancer patients.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658343"
  },
  "e07cb0137cfa16fe": {
    "source": "pubmed",
    "title": "Deciphering molecular pathways driving cancer invasion and metastasis: advances and therapeutic prospects.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658345"
  },
  "185ef30b172f659c": {
    "source": "pubmed",
    "title": "Small extracellular vesicle-associated surface protein biomarkers: emerging roles, opportunities, and challenges in diagnostics.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658347"
  },
  "819b0d251ecbd9f3": {
    "source": "pubmed",
    "title": "AND-Gate Logic-Controlled Catalytic Hybridization Network for Robust Dual-Mode Fluorescence-Colorimetric Detection of Breast Cancer miRNAs.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658349"
  },
  "07f4cf228233bb5a": {
    "source": "pubmed",
    "title": "Nanopore based RNA methylation profiling of a circulating lung cancer biomarker.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658352"
  },
  "6de37f5c1a16bc26": {
    "source": "pubmed",
    "title": "Bile cell-free DNA shows benefit as a potential sample for somatic mutation detection of resectable cholangiocarcinoma.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658354"
  },
  "6ec225e438d33598": {
    "source": "pubmed",
    "title": "Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658356"
  },
  "04bc8291e756f57d": {
    "source": "pubmed",
    "title": "Genotype-specific Human Papillomavirus patterns and their implications across the cervical cancer spectrum: A cross-sectional study from Western India.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658358"
  },
  "04534d2ea9f25396": {
    "source": "pubmed",
    "title": "The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658360"
  },
  "f59c500fe7d39c7d": {
    "source": "pubmed",
    "title": "The democratization of cancer screening, or a waste of valuable resources?",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658362"
  },
  "f766050e07d43fcd": {
    "source": "pubmed",
    "title": "Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658364"
  },
  "a1b756dced105c13": {
    "source": "pubmed",
    "title": "Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658366"
  },
  "de9ce1efba5ba112": {
    "source": "pubmed",
    "title": "Plasma Extracellular Vesicles as Liquid Biopsies for Glioblastoma: Biomarkers, Subpopulation Enrichment, and Clinical Translation.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658370"
  },
  "3b2d00d8d45691b6": {
    "source": "pubmed",
    "title": "Identification of Colorectal Cancer-Related RNA Markers from Whole Blood Using Integrated Bioinformatics Analysis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658372"
  },
  "cce75b42d27ddb41": {
    "source": "pubmed",
    "title": "Liquid biopsies across the cancer care continuum.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658374"
  },
  "9296823a9ddb9dd8": {
    "source": "pubmed",
    "title": "Schlafen 11 as a predictive biomarker and therapeutic target in cancer: From mechanisms to clinical application.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658376"
  },
  "e7338322142cd938": {
    "source": "pubmed",
    "title": "Artificial Intelligence for Liquid Biopsy: FTIR Spectroscopy and Autoencoder-Based Detection of Cancer Biomarkers in Extracellular Vesicles.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658378"
  },
  "c6d0d48cd52a4be4": {
    "source": "pubmed",
    "title": "Lung Cancer Diagnosis and Prognostic Monitoring Through Cell-Free RNA via Liquid Biopsy.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658380"
  },
  "00288168a4d84689": {
    "source": "pubmed",
    "title": "Exosomal biomarkers and therapeutics in lung cancer: a narrative review on their role in early detection and targeted treatment.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658382"
  },
  "7891da5039da4e65": {
    "source": "pubmed",
    "title": "[Pseudoprogression after start of immunotherapy].",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658384"
  },
  "f9a0e45934b6e1bd": {
    "source": "pubmed",
    "title": "Transforming Gynecologic Cancer Care Through Artificial Intelligence: A Clinician's Guide to the Evolving Landscape.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658386"
  },
  "a4916a9a86b2b5bb": {
    "source": "pubmed",
    "title": "Label-Free Probes and Magneto-Thermal Imprinting Enable Rapid Multiplexed Exosomal Profiling for Breast Cancer Classification.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658388"
  },
  "4581c4c2fbff620e": {
    "source": "pubmed",
    "title": "Anionic Liposomes as Optimal Membrane Fusion Carriers Enabling in Situ Multiplexed Detection of Extracellular Vesicle MicroRNAs.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658390"
  },
  "1539ffe92be499b1": {
    "source": "pubmed",
    "title": "Tumor Genomic and Transcriptomic Analysis Integrated With Liquid Biopsy ctDNA Monitoring: Analytical Validation and Clinical Insights.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658392"
  },
  "10eb44efad427cd7": {
    "source": "pubmed",
    "title": "A Plasma-based Deep Proteomic Platform for Early-Stage Breast Cancer Detection.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658394"
  },
  "aadfd1a14829c99d": {
    "source": "pubmed",
    "title": "Multicolor SERS-encoded immuno-cocktail for longitudinal precise tracking of CTCs phenotypes in lung cancer therapeutics.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658396"
  },
  "16e348922daeab7b": {
    "source": "pubmed",
    "title": "Emerging biomarkers in prostate cancer diagnosis and treatment: Insights into genetic, RNA and metabolic markers (Review).",
    "company": "",
    "discovered_at": "2025-12-30T08:42:11.658398"
  },
  "f225580cee246689": {
    "source": "pubmed",
    "title": "Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465001"
  },
  "cb5572258a8f3845": {
    "source": "pubmed",
    "title": "Homogeneous Extraction-Free Dual-ctDNA Detection via DNA Nanomaterial Fusion for Rapid Breast Cancer Diagnosis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465011"
  },
  "715872dbe7106ab2": {
    "source": "pubmed",
    "title": "Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465016"
  },
  "467b345f7f9407bf": {
    "source": "pubmed",
    "title": "Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465021"
  },
  "fab7ded86367bff4": {
    "source": "pubmed",
    "title": "Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465029"
  },
  "b1f615b5bedbc1cc": {
    "source": "pubmed",
    "title": "Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465034"
  },
  "44f953872ee84c40": {
    "source": "pubmed",
    "title": "A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:12.465039"
  },
  "fe2e833852b2a41e": {
    "source": "pubmed",
    "title": "Cerebrospinal fluid ctDNA as a diagnostic and prognostic tool in gliomas: a systematic review and meta-analysis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490621"
  },
  "b5f7b816e40b4e16": {
    "source": "pubmed",
    "title": "Blood-Based Biomarkers for Pulmonary Nodule Risk Stratification: A Systematic Review and Meta-Analysis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490634"
  },
  "6c6eaf1ebce09b2a": {
    "source": "pubmed",
    "title": "Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490639"
  },
  "c16035c012a5d151": {
    "source": "pubmed",
    "title": "Comparative predictive value of immunotherapy biomarkers: a systematic review and network meta-analysis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490643"
  },
  "2593244d0562ee73": {
    "source": "pubmed",
    "title": "From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490647"
  },
  "cae87cfb3db95491": {
    "source": "pubmed",
    "title": "Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5\u2009years?",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490664"
  },
  "1949f95aff37a492": {
    "source": "pubmed",
    "title": "MED: Multiplexed, Entropy-Driven Catalysis, Single-Nucleotide-Resolved ctDNA Detection.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490668"
  },
  "b74abb46c8c534f0": {
    "source": "pubmed",
    "title": "Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490672"
  },
  "d8e620dbed4a3268": {
    "source": "pubmed",
    "title": "Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from methylated DNA sequencing data.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490680"
  },
  "30aeebead78b5674": {
    "source": "pubmed",
    "title": "AND logic-gated CRISPR/Cas9 and hybridization chain reaction system for precise ctDNA detection.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490684"
  },
  "4fb9f5c21779b0d9": {
    "source": "pubmed",
    "title": "20(th) anniversary of adjuvant trastuzumab: reflections on a breakthrough moment.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490688"
  },
  "6f8594c53cfdeb57": {
    "source": "pubmed",
    "title": "Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490693"
  },
  "0d03ad38b803a767": {
    "source": "pubmed",
    "title": "Translational Relevance of the Genomic Landscape of KRAS(G12D)-Mutant Colorectal and Pancreatic Cancers.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490704"
  },
  "4650429616534dff": {
    "source": "pubmed",
    "title": "Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490712"
  },
  "45e7dacd0fc68ab9": {
    "source": "pubmed",
    "title": "Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490716"
  },
  "582ed221693b2c70": {
    "source": "pubmed",
    "title": "Artificial intelligence and multi-omics integration in liquid biopsy for genitourinary cancers: a systematic scoping review.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490732"
  },
  "213159bc8149bb67": {
    "source": "pubmed",
    "title": "Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490737"
  },
  "f01a95629c42778a": {
    "source": "pubmed",
    "title": "Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490742"
  },
  "a04b7d2c1204cc5a": {
    "source": "pubmed",
    "title": "Evaluating Circulating Tumor DNA Clearance as an Early Intermediate End Point Predicting Clinical Benefit in Metastatic Nonsquamous NSCLC After First-Line Chemoimmunotherapy.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490747"
  },
  "d70229f5ba8ef5f0": {
    "source": "pubmed",
    "title": "Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490751"
  },
  "cb38c7d89483812a": {
    "source": "pubmed",
    "title": "Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490755"
  },
  "7b72b92a6d43ed4f": {
    "source": "pubmed",
    "title": "Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490759"
  },
  "b59985e5f917065f": {
    "source": "pubmed",
    "title": "ESR1 ctDNA testing: literature review and comparison of assays for ESR1 mutation detection in advanced hormone receptor-positive breast cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490764"
  },
  "4271282685f8ce01": {
    "source": "pubmed",
    "title": "The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490768"
  },
  "fdb5b7864b74baa2": {
    "source": "pubmed",
    "title": "An umbrella review of systematic reviews on the diagnostic and prognostic utility of circulating tumor DNA and MicroRNA in colorectal cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490772"
  },
  "c92d5d085d587df0": {
    "source": "pubmed",
    "title": "Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490776"
  },
  "03013a864934f8b1": {
    "source": "pubmed",
    "title": "Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490780"
  },
  "758e90c2c55f5c28": {
    "source": "pubmed",
    "title": "Tumor-informed circulating tumor DNA detection for personalized monitoring of treatment response in epithelial ovarian cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490788"
  },
  "4968817bf46c840a": {
    "source": "pubmed",
    "title": "Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:13.490798"
  },
  "0981b82a76facb25": {
    "source": "pubmed",
    "title": "Sequential pseudoallogeneic CAR20/22/19 T-cell therapy in patient with diffuse large B-cell lymphoma relapse after allo-HSCT: a case report.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:14.262070"
  },
  "de835470ad478989": {
    "source": "pubmed",
    "title": "Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:14.262124"
  },
  "875359bdd288ca7e": {
    "source": "pubmed",
    "title": "A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST).",
    "company": "",
    "discovered_at": "2025-12-30T08:42:14.262135"
  },
  "cfcc4b986047b1cd": {
    "source": "pubmed",
    "title": "Novel Near Infrared Dyes Targeting Carbonic Anhydrase IX for Fluorescence Imaging Applications.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:14.262145"
  },
  "79ee528c8a22db44": {
    "source": "pubmed",
    "title": "Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and Management.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:15.711815"
  },
  "684b6f12f7b67af8": {
    "source": "pubmed",
    "title": "Browser-Based Multi-Cancer Classification Framework Using Depthwise Separable Convolutions for Precision Diagnostics.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:15.711835"
  },
  "35576a739b9d303f": {
    "source": "pubmed",
    "title": "Programmable Argonaute-mediated single-nucleotide variant sequencing of cell-free DNA for multi-cancer early detection.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:15.711840"
  },
  "8e582aea46ce7e63": {
    "source": "pubmed",
    "title": "How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to Know.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219701"
  },
  "936e7a447be01db0": {
    "source": "pubmed",
    "title": "Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219716"
  },
  "f775025d62582252": {
    "source": "pubmed",
    "title": "Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219722"
  },
  "2057319df69ffd47": {
    "source": "pubmed",
    "title": "Rapidly evolving therapeutic advances for classical EGFR-mutant NSCLC.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219726"
  },
  "13e4d77c35ba7952": {
    "source": "pubmed",
    "title": "Exploring coding and signal joints of novel TCR beta D-D rearrangements for tracking T-cell leukemia clonality.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219730"
  },
  "9aabb34fc88ebb9e": {
    "source": "pubmed",
    "title": "Validation of an Adapted NGS-Based Clonality Assay for MRD Monitoring in B-ALL Using Archived and Follow-Up Samples.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219737"
  },
  "98e74fad61dfda52": {
    "source": "pubmed",
    "title": "Azacitidine as maintenance therapy in pediatric de novo acute myeloid leukemia.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219741"
  },
  "bafc82bab6b2b208": {
    "source": "pubmed",
    "title": "Evaluation of Circulating miR-155, miR-221, miR-34a, and miR-143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219744"
  },
  "3bb6f814b19c5d9c": {
    "source": "pubmed",
    "title": "Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219752"
  },
  "22ac99471080ba38": {
    "source": "pubmed",
    "title": "Beyond the DNA sequence: mapping the dynamic epigenetic landscape for risk stratification and therapeutic intervention in acute myeloid leukemia.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219755"
  },
  "08e9ba3ec722784e": {
    "source": "pubmed",
    "title": "Evaluation of iMS-IP assay for the detection and typing of monoclonal immunoglobulins.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219759"
  },
  "65aa014cccef4566": {
    "source": "pubmed",
    "title": "Clinical Integration and Evaluation of the STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) Intervention.",
    "company": "",
    "discovered_at": "2025-12-30T08:42:17.219762"
  },
  "6a632ea5d96915ce": {
    "source": "news",
    "title": "Potential announcement - Grail",
    "company": "Grail",
    "discovered_at": "2025-12-30T08:42:18.679930"
  },
  "b8f50d78a7c8f51c": {
    "source": "news",
    "title": "Potential announcement - Invitae",
    "company": "Invitae",
    "discovered_at": "2025-12-30T08:42:26.440174"
  },
  "d4e0e450f17e33c6": {
    "source": "clinicaltrials",
    "title": "Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.203908"
  },
  "62117ec2c07a32b8": {
    "source": "clinicaltrials",
    "title": "A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents",
    "company": "Sun Yat-sen University",
    "discovered_at": "2025-12-30T08:42:27.203963"
  },
  "6e1511eb05d2fb61": {
    "source": "clinicaltrials",
    "title": "Non-Invasive Postoperative Recurrence Monitoring After Neoadjuvant Immunotherapy in Lung Cancer",
    "company": "Peking University People's Hospital",
    "discovered_at": "2025-12-30T08:42:27.203999"
  },
  "4f5f271a5ac7b84a": {
    "source": "clinicaltrials",
    "title": "Using ctDNA to Determine Therapies for Lung Cancer",
    "company": "University Health Network, Toronto",
    "discovered_at": "2025-12-30T08:42:27.204015"
  },
  "b131740e4c71bf2a": {
    "source": "clinicaltrials",
    "title": "Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer",
    "company": "Qurasense",
    "discovered_at": "2025-12-30T08:42:27.204026"
  },
  "581c751c57413ea8": {
    "source": "clinicaltrials",
    "title": "CfDNA in Hereditary And High-risk Malignancies 2",
    "company": "University Health Network, Toronto",
    "discovered_at": "2025-12-30T08:42:27.204035"
  },
  "63d10b6651028d79": {
    "source": "clinicaltrials",
    "title": "Cell-free DNA in Hereditary And High-Risk Malignancies",
    "company": "University Health Network, Toronto",
    "discovered_at": "2025-12-30T08:42:27.204044"
  },
  "4f8fad9b9d21bf7f": {
    "source": "clinicaltrials",
    "title": "A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma",
    "company": "City of Hope Medical Center",
    "discovered_at": "2025-12-30T08:42:27.204052"
  },
  "52a37c872137eb4d": {
    "source": "clinicaltrials",
    "title": "Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting",
    "company": "City of Hope Medical Center",
    "discovered_at": "2025-12-30T08:42:27.204062"
  },
  "edca232c8ec81594": {
    "source": "clinicaltrials",
    "title": "Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma",
    "company": "RenJi Hospital",
    "discovered_at": "2025-12-30T08:42:27.204071"
  },
  "840dd353a941b34f": {
    "source": "clinicaltrials",
    "title": "Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.",
    "company": "Swiss Cancer Institute",
    "discovered_at": "2025-12-30T08:42:27.941885"
  },
  "12766c918233acda": {
    "source": "clinicaltrials",
    "title": "Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941906"
  },
  "5be19f589074c9fb": {
    "source": "clinicaltrials",
    "title": "Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941912"
  },
  "05508ac5deb6b566": {
    "source": "clinicaltrials",
    "title": "Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941917"
  },
  "dfdce8f8cef5e698": {
    "source": "clinicaltrials",
    "title": "Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941922"
  },
  "8f165a4d058f07bd": {
    "source": "clinicaltrials",
    "title": "Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941927"
  },
  "c6973a8c57cac7af": {
    "source": "clinicaltrials",
    "title": "A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population",
    "company": "MedSIR",
    "discovered_at": "2025-12-30T08:42:27.941932"
  },
  "c5a0323c1af3ed28": {
    "source": "clinicaltrials",
    "title": "Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941937"
  },
  "ab7b66068528e115": {
    "source": "clinicaltrials",
    "title": "Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941942"
  },
  "2353dbe176d6dbab": {
    "source": "clinicaltrials",
    "title": "Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:27.941947"
  },
  "670bf3918c358854": {
    "source": "clinicaltrials",
    "title": "Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance",
    "company": "Universal Diagnostics",
    "discovered_at": "2025-12-30T08:42:28.603177"
  },
  "c368ab6cf113b641": {
    "source": "clinicaltrials",
    "title": "A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma",
    "company": "Memorial Sloan Kettering Cancer Center",
    "discovered_at": "2025-12-30T08:42:28.603204"
  },
  "cb6ad0d80200757c": {
    "source": "clinicaltrials",
    "title": "A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)",
    "company": "Hoffmann-La Roche",
    "discovered_at": "2025-12-30T08:42:28.603211"
  },
  "c3bdfe16ae06e0a2": {
    "source": "clinicaltrials",
    "title": "Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma",
    "company": "Melanoma Institute Australia",
    "discovered_at": "2025-12-30T08:42:28.603217"
  },
  "e4a59fdde29b312a": {
    "source": "clinicaltrials",
    "title": "A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)",
    "company": "Hoffmann-La Roche",
    "discovered_at": "2025-12-30T08:42:28.603229"
  },
  "e4996499629ff5a1": {
    "source": "clinicaltrials",
    "title": "Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma",
    "company": "Diwakar Davar",
    "discovered_at": "2025-12-30T08:42:28.603234"
  },
  "f45883efa4cd3287": {
    "source": "clinicaltrials",
    "title": "EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations",
    "company": "Dana-Farber Cancer Institute",
    "discovered_at": "2025-12-30T08:42:28.603239"
  },
  "9b10c544ed855a45": {
    "source": "clinicaltrials",
    "title": "Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene",
    "company": "National Cancer Institute (NCI)",
    "discovered_at": "2025-12-30T08:42:28.603257"
  }
}